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INTRODUCTION
Malignant melanoma, originated from melanocytes, is not
a common cancer and is found only in about 1-3% of all cancer
patients (1). Its incidence in Korea is still low, not reaching
at 1% (2). Distant metastasis through the lymphatic and
hematogenous pathway is frequent in malignant melanoma.
Although metastasis to the gastrointestinal tract is invari-
ably found in about 50-60% of autopsy cases, the incidence
of being found alive is about 4% (3, 4); the small intestine is
the most commonly involved site in the gastrointestinal tract.
Primary malignant melanoma, though extremely rare, has
been reported. However the presence of primary malignant
melanoma in the gastrointestinal tract other than the esoph-
agus and rectum where melanocytes normally exist, is con-
troversial (5, 6). We experienced a case of malignant melanoma
having aneurysmal dilatations with no confirmed primary
lesion.
CASE REPORT
A 36-yr-old woman was admitted to the hospital because
of intermittent fever, chill, indigestion and colicky abdomi-
nal pain that had developed about three weeks ago. On admis-
sion, her vital signs were unstable. The blood pressure was
at 80/60 mmHg, the pulse was at 110/min but normal, the
respirations were at 20/min, and the temperature was at 38
℃. On physical examination, she showed abdominal disten-
sion with moderate tenderness of the lower abdomen but no
rebound tenderness. A spherical mass was palpated at the
lower abdomen but the bowel sound was normal. Pitting
edema was observed in both legs.
After laboratory workup, severe anemia was unveiled: The
hemoglobin was 4.3 mg/dL, the hematocrit 12.9%, the white-
cell count 23,600/ L (segment neutrophil 77%), the platelet
count 685,000/ L, reticulocyte 2.3%, MCH 26 picograms,
MCV 77.7 femtoliters, MCHC 33.4%, serum iron 5  g/dL,
and total iron-binding capacity 131  g/dL. Peripheral blood
smears yielded two plus for toxic granules and the Coomb’ s
test was negative. On biochemical study, the level of serum
sodium was low at 129 mEq/L, while potassium, calcium,
phosphorus, magnesium, urea nitrogen, creatinine, aspartate
aminotransferase, and alanine transferase were normal. Bone
marrow biopsy was followed for the evaluation of her anemia.
It resulted in the typical feature of a chronic disease; cellular-
ity of 70-80%, G:E ratio of 10:1, and granulocytic hyperplasia
of the bone marrow. Endoscopic evaluations were performed
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Ileal Malignant Melanoma Presenting as a Mass with Aneurysmal
Dilatation
: A Case Report
Malignant melanoma is the most common metastatic tumor of the gastrointestinal
tract and can present with fairly common constitutional symptoms. A 36-yr-old woman
was found to have a secondary malignant melanoma in the terminal ileum with pro-
fuse aneurysmal dilatation, which is not the typical presentation of the malignant
melanoma in the small intestine. Radiologic studies revealed a large tumor involv-
ing the distal ileum with aneurysmal dilatations having afferent and efferent loops,
which needed to be differentiated from malignant lymphoma and other gastroin-
testinal tumors. Exploratory laparotomy was done, and we found a huge mass with
plentiful aneurysmal dilatations; much the same of the findings from the previous
studies. Segmental resection with the surrounding omentum was done followed
by end-to-end anastomosis between both ends of the remaining ileum. She had
been free from any evidence of the local or systemic recurrence for one year after
the completion of eighteen months of the subcutaneous interferon treatment; post-
operatively however, the occurrence of metastatic mass at the right axilla rendered
us from complete resection due to severe penetration into the vital nerves and ves-
sels in the axilla. 
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to rule out the possibility of anemia from the intestinal origin
with no abnormal findings found in the stomach, duodenum,
colon, and rectum. On radiologic evaluation, slight hyper-
trophy of the heart was found on plain chest radiograph. A
mass accompanied by numerous aneurysmal dilatations at the
terminal ileum was initially found by the ultrasonography,
which is usually the finding of a lymphoma or submucosal
tumor with ulcer. Small amount of ascites, slight splenomegaly,
and a benign-looking hepatic cyst were also found on ultra-
sonography. A computed tomography was followed, which
showed exactly the same findings of ultrasonography (Fig. 1).
According to the small bowel series along with the previous
radiologic findings, a lymphoma or gastrointestinal stromal
tumor having marked aneurysmal dilatations was suspected
(Fig. 2).
After treating anemia with repeated transfusion, explorato-
ry laparotomy was done. After evacuating moderate amount
of intraabdominal ascites, we could locate a mass at the termi-
nal ileum, which resided in the middle of the lower abdomen
and attached firmly to the omentum anteriorly, the sigmoid
colon posteriorly, and the urinary bladder inferiorly. The diam-
eter of the mass exceeded 15 centimeters, and the intervening
normal segment of the ileum between the mass and the ileo-
cecal valve was 10 centimeters in length. The mass had ser-
pentine aneurysmal dilatations around it, but no lymphade-
Fig. 1. Abdominal computerized tomography shows marked dilata-
tion of the distal ileum and no obstructive lesion.
Fig. 2. Small bowel series shows submucosal tumor at distal ileum,
suggesting a lymphoma with aneurysmal dilatations or gastroin-
testinal stromal tumor.
Fig. 3. There is markedly dilated lumen in the mass in connection
with the lumen of afferent loop (arrowhead) and efferent loop with
normal ileal mucosa (arrow).
Fig. 4. The microscopic findings of the tumor cells are markedly
irregular in size and shape, showing large cells with hyperchro-
matic nuclei, prominent nucleoli, and abundant eosinophilic cyto-
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nopathy was found around the mass. The patient underwent
segmental resection of the involved ileum along with the
mesentery. Unfortunately, we had to sacrifice her right adnexa
and some part of the bladder wall due to severe adhesion with
the mass. By dividing the mass longitudinally, we could see
a necrotic tumor with nodules on the serosal surface of the
diseased ileum having normal looking proximal and distal
small intestinal loops attatched to it (Fig. 3). Grossly, the speci-
mens were previously opened and continuous segment of
terminal ileum, 44 cm long, and cecum and ascending colon,
18 cm long. The lumen of the small intestine was markedly
dilated, about 15 cm in diameter, at 26 cm from the proximal
margin of resection and showed tan gray dull and nodular
serosal surface. It showed diffusely thickened wall, up to 25
cm, and showed tan gray nodular luminal surface. Formalin-
fixed and paraffin-embedded sections of the small intestine
showed infiltration of the nests of epithelioid tumor cells. The
tumor cells showed marked cytologic atypia with large eosi-
nophilic nucleoli, abundant mitotic figures, and abundant
cytoplasm (Fig. 4). Melanin pigment was focally present in
the cytoplasm. After immunohistochemical staining with
HMB-45 and S-100, the diagnosis of the malignant melanoma
infiltrating to the ileal mucosa was confirmed (Fig. 5).
Thorough postoperative systemic evaluations were done to
disclose the primary site of the malignant melanoma but ended
without significant results. We did find a nevus at the left
upper lip, but biopsy results only revealed it as a melanocyt-
ic nevus within the dermis.
Since the first operation, she had had systemic interferon
treatment for eighteen months. During the period of systemic
therapy, she did not show any evidence of local or systemic
recurrence. After the eighteen months of the treatment, we
could not continue to follow up on her. About one year after
the initial operation, however, she visited our hospital with a
huge mass measuring at 15 cm in diameter at her right axilla.
The mass showed very aggressive phenotype and at the sec-
ond operation we failed to remove the mass completely due
to its penetration and invasion into the nerves and vessels in
the axilla. The histopathological examination with immuno-
histochemical staining confirmed the recurrence.
DISCUSSION
Malignant melanoma is a relatively rare tumor comprising
1-3% of all tumors. Mucosal melanoma is especially rare with
its rate of incidence of only 3% in Caucasians. Although metas-
tasis of malignant melanoma to the gastrointestinal tract is
frequently seen in autopsy cases up to 50-60%, only two to
five percent of patients are diagnosed with malignant melanoma
while they are alive (3, 4, 7). It is because that there are no
specific symptoms of early development, which are general
and constitutional; and even if they do occur, they are usual-
ly accompany with symptoms such as abdominal pain (62%),
hemorrhage (50%), nausea and vomiting (26%), mass (22%),
and intestinal obstruction (18%), so it usually is diagnosed
in the emergency situation after metastasis occurs (8). Meta-
stasis to the gastrointestinal tract is seen most frequently in
the small intestine, followed by the colon, stomach, and rec-
tum but is rare in the esophagus. However, primary malig-
nant melanoma originating in the small intestine is extreme-
ly rare. Characteristically, the time interval between the iden-
tification of the primary malignant melanoma to the diagno-
sis of metastasis to the gastrointestinal tract can be long from
2 to 180 months, and the primary lesion is not be defined in
8% (8, 9). It was suggested that the primary lesion may be
lost naturally, or small and extensive metastasis could occur
before any changes are observed (10). The following diagnos-
tic criteria are proposed, though the controversy still exists
over the presence of primary malignant melanoma in areas
other than the esophagus and rectum. According to Sachs et
al., primary malignant melanoma is diagnosed in the small
intestine where there are 1) biopsy-proven melanoma from
the small intestine at a single focus, 2) no evidence of disease
in any other organs including the skin (no evidence of regressed
primary melanoma), eye and lymph nodes outside the region-
al drainage at the time of diagnosis, and 3) disease-free sur-
vival of at least 12 months after diagnosis (11). According to
Blecker et al., it is diagnosed when there are lack of concur-
rent or previous removal of a melanoma or atypical melanocyt-
ic lesion from the skin and lack of other organ involvement
and in situ change in the overlying or adjacent GI epitheli-
um (12). Allen and Spitz claimed that the diagnosis is made
when there are 1) characteristic structure of melanoma and
melanin pigment, 2) presence of melanocytes in the adjacent
epithelium, 3) polypoidal growth, and 4) when melanoma is
originated from the areas having junctional activity within
the squamous epithelium (13). However, these criteria are fit
only in 40% of esophagus melanoma considered as primary
malignant melanoma (14). More than 50% of the lesions of
the small intestine are polypoid. Aneurysmal dilatation in the
Fig. 5. Result of immunohistochemical staining with HMB-45 is
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small intestine seen in our patient showed the typical findings
of malignant lymphoma. There are the following five char-
acteristic appearances of lymphomatous involvement of the
small intestine according to radiologic classification: 1) mul-
tiple intraluminal nodular defects; 2) polypoid form causing
intussusception; 3) endo-exo-enteric form with excavation
and multiple fistula formations; 4) invasive form of the mesen-
tery with large extraluminal masses; and 5) infiltrating form
(15). The aneurysmal form belongs to the fifth one. Aneurys-
mal dilatations are the results of the diffuse infiltration of
the intestinal segment. As they advance, destruction by the
tumor becomes so extensive that the lumen appears as a large
cavity. Although aneurysmal dilatation that we encountered
is seen more frequently in a primary tumor such as lymphoma,
or leiomyosarcoma, some studies report that such form can
appear in lesions of the small intestine metastasized from
primary lesions such as malignant melanoma, squamous cell
carcinoma of the lung, adenocarcinoma of the rectum, and
endometrial stromal sarcoma (16), indicating that this metas-
taic lesion with aneurysmal dilatation may be hematogeneous
in origin. Enteroclysis was suggested as a method for diag-
nosis, but is unreliable in demonstrating melanoma metas-
tases to the small bowel, as is computerized tomography.
Primary treatment for malignant melanoma is an extensive
and curative surgery, if possible, because other methods includ-
ing radiotherapy, chemotherapy and immunotherapy cannot
offer definite treatment outcome. It is known that the prog-
nosis of mucosal melanoma is poor compared with the malig-
nant melanoma of the skin and prognosis is also poor when
metastasis to the gastrointestinal tract is present, with the
average survival period being 4-6 months (17). However, the
median length of survival was reported to be from 23 to 48
months when complete surgical resection was possible (8).
Early diagnosis is important in treating malignant melanoma,
since the primary modality of treatment is surgical opera-
tion. The aggressive surgical resection is essential even in
the presence of metastasis to the gastrointestinal tract, since
surgery is not only a palliative modality but also affects the
prognosis (2, 17); so it should be considered primarily in
selected patients.
Though the possibility of primary malignant melanoma in
the small intestine do exist, the incidence is extremely low.
Though the previous nevus near the mouth seemed not likely
to be the primary focus in the present case, we could not com-
pletely rule out the possibility. The pattern of growth of the
small intestinal lesion was not polypoid and melanocytes were
not found in the adjacent epithelium. So, we presumed the
lesion at the terminal ileum to be the secondary malignant
melanoma from an unknown primary site.
Ileal malignant melanoma with diffuse serpentine aneurys-
mal dilatation is an extremely rare and unusual condition,
which must be differentiated from other intestinal tumors, but
it is not possible to obtain a definite diagnosis before the patho-
logical confirmation. Immunohistochemical staining with
antimelanoma antibody and HMB-45 is, however, found to
substantiate the diagnosis.
In conclusion, metastatic melanoma in the small bowel
should be suspected in any patient with a previous history of
malignant melanoma or atypical melanocytic nevus who devel-
ops gastrointestinal symptoms or chronic blood loss leading
to moderate or severe anemia. Presenting symptoms are non-
specific such as anemia, abdominal pain, nausea and vomiting.
Small bowel involvement by melanoma, even without a known
primary focus, is most probably metastatic. Surgical treatment
is the first choice; the prognosis after surgical resection was
much better than for other organ metastases or simultaneous
metastases of the small bowel and other organs. There appear
to be two subsets of primary melanoma: one that occurs among
younger patients, which is more aggressive with rapid metas-
tases and early death and another one that occurs among older
patients, being more indolent with less rapid metastasis (18).
The relatively high 5-yr survival rate associated with com-
plete surgical resection of gastrointestinal tract metastases
indicates that surgery should be strongly considered for this
type of patients.
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